YCBD
cbdMD Inc
NYSE MKT: YCBD · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.85
-2.02% today
Updated 2026-04-30
Market cap
$10.18M
P/E ratio
1.62
P/S ratio
0.53x
EPS (TTM)
$0.60
Dividend yield
—
52W range
$0 – $3
Volume
1.8M
WallStSmart proprietary scores
28
out of 100
Grade: F
Strong Sell
Investment rating
2.7
Growth
F5.0
Quality
C+2.0
Profitability
F8.3
Valuation
A—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →200 stocks currently score above 75
Price targets
Analyst target
$2.00
+135.29%
12-Month target
$0.74
-12.94%
Intrinsic (DCF)
$3.16
Margin of safety
+76.15%
Price chart
X-Ray snapshot
Strengths
+ 76.15% below intrinsic value
Risks
- Thin margins at -12.20%
- Negative free cash flow $-165.61M
- Revenue declining -1.90% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $35.40M | $24.16M | $19.48M | $19.19M | $19.09M |
| Net income | $-70.08M | $-22.94M | $-3.70M | $-2.04M | $-283131.00 |
| EPS | — | — | — | — | $0.60 |
| Free cash flow | $-15.66M | $-4.60M | $-642807.00 | $-1.64M | $-165.61M |
| Profit margin | -197.96% | -94.96% | -18.99% | -10.63% | -12.20% |
Peer comparison
Smart narrative
cbdMD Inc trades at $0.85. representing a P/E of 1.62x trailing earnings. Our Smart Value Score of 28/100 indicates the stock is weak. TTM revenue stands at $19.09M. with profit margins at -12.20%. Our DCF model estimates intrinsic value at $3.16.
Frequently asked questions
What is cbdMD Inc's stock price?
cbdMD Inc (YCBD) trades at $0.85.
Is cbdMD Inc overvalued?
Smart Value Score 28/100 (Grade F, Strong Sell). DCF value $3.16.
What is the price target of cbdMD Inc (YCBD)?
The analyst target price is $2.00, representing +135.3% upside from the current price of $0.85.
What is the intrinsic value of cbdMD Inc (YCBD)?
Based on our DCF model, intrinsic value is $3.16, a +76.2% margin of safety versus $0.85.
What is cbdMD Inc's revenue?
TTM revenue is $19.09M.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNYSE MKT
CurrencyUSD
Quick metrics
P/S ratio0.53x
ROE-43.40%
Beta2.10
50D MA$0.79
200D MA$0.89
Shares out0.01B
Float0.01B
Short ratio—
Avg volume1.8M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—